Mead Johnson Nutrition CO (MJN) : Pensionfund Dsm Netherlands has sold out all of its stake in Mead Johnson Nutrition CO during the most recent quarter, according to a report filed by the company on Apr 4, 2016 with the SEC. The investment management company has sold out 45,000 shares of Mead Johnson Nutrition CO which is valued at $3.8 Million.
Other Hedge Funds, Including , Pensionfund Sabic sold out all of its stake in MJN during the most recent quarter. The investment firm sold 21,500 shares of MJN which is valued $1.8 Million.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.78 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jan 28, 2016. Analyst had a consensus of $0.73. The company had revenue of $967.00 million for the quarter, compared to analysts expectations of $974.46 million. The company’s revenue was down -11.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.92 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016. Mead Johnson Nutrition CO was Downgraded by Nomura to ” Neutral” on Jan 12, 2016. Mead Johnson Nutrition CO was Downgraded by JP Morgan to ” Neutral” on Jan 11, 2016.
Mead Johnson Nutrition CO closed down -0.12 points or -0.14% at $84.45 with 8,61,991 shares getting traded on Monday. Post opening the session at $84.79, the shares hit an intraday low of $84.42 and an intraday high of $85.44 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.